Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China

NANot yet recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2028

Conditions
Severe Aortic Valve Stenosis
Interventions
OTHER

All aortic valve products on the market

"1. Subjects with severe aortic valve stenosis~2. Subjects who plan (or have) to use the transcatheter aortic valve replacement system for percutaneous aortic valve replacement~3. The patients agreed to join the study, voluntarily signed the informed consent and completed the follow-up;~4. Be able to contact the subjects or their legal guardians / relatives;~5. The medical record records the subjects who have died and can't get any contact information of the subjects( (for dead cases only)~Sign the informed consent form, then check the inclusion and exclusion criteria, register after meeting the criteria, obtain the registration number, perform aortic valve replacement surgery, follow-up 24 hours, discharge, 30 days, 1 year, 2 years, 3 years, 4 years and 5 years after operation according to the test requirements, and carry out relevant follow-up according to the scheme requirements to collect data"

All Listed Sponsors
collaborator

Hangzhou Qiming Medical Instrument Co., Ltd

UNKNOWN

lead

CCRF Inc., Beijing, China

INDUSTRY